EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis

Martina Tedesco, Elisa Delbarba, Martina Uzzo, Gianmarco Lugli, Chiara Bedognè, Marta Salti, Francesco Ravelli, Corrado Damilano, Eva Sestagalli, Marta Arrighini, Simona Fisogni, Vincenzo L'Imperio und 17 weitere

Clinical Kidney Journal · 02.11.2026 · 19 (11)

DOI: 10.1093/ckj/sfag350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 05.10.2026. Verfasst von Martina Tedesco und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Italian Ministry of the University MUR, School of Medicine and Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the key pathogenetic role of the complement cascade in various immune-mediated kidney diseases, the clinical significance of serum C3/C4 levels in conditions where most patients exhibit complement levels within normal limits, such as membranous nephropathy (MN) and ANCA (antineutrophil cytoplasmic antibody)-glomerulonephritis (ANCA-GN), remains underexplored. This study focused on the clinico-pathological correlates of serum complement C3/C4 levels in two cohorts of patients with biopsy-proven MN and ANCA-GN.

Methods

Based on median C3 and C4 levels at time of diagnostic biopsy, the cohorts were stratified into four groups, referred to as “complement component-high” and “-low.” Clinico-pathological features were compared between these groups and correlated with C3/C4 levels.

Results

In the MN cohort (n = 44), patients in the C3-low group showed a higher degree of global (8.3% vs 0%, p = .015) and combined global and segmental glomerulosclerosis (9.5% vs 0%, p = .032) compared to the C3-high group. In the ANCA-GN cohort (n = 198), serum C3 levels were lower in cases with the sclerotic class according to Berden classification (107 [98–123] mg/dl) compared to those classified as focal (138 [112–151] mg/dl, p < .001), crescentic (127 [107–151] mg/dl, p = .003), or mixed (123 [101–140] mg/dl, p = .018). Furthermore, ANCA-GN patients in the C3-low group showed lower estimated glomerular filtration rate at presentation and serum C3 was inversely associated with the risk of kidney failure, independently of several confounders (Hazard ratio [HR] for 10 mg/dl increase in C3: 0.91, 95% Confidence Interval [CI] 0.83–1.00, p = .049).

Conclusions

Serum C3 levels in the low-normal range were associated with glomerulosclerosis in both ANCA-GN and MN, and with poorer kidney outcome in ANCA-GN, supporting a potentially cross-disease role of the complement cascade in mediating glomerular injury.

Schlagwörter

Stichwörter der Autor:innen

ANCA-glomerulonephritisC3complementglomerulosclerosismembranous nephropathy

Autor:innen und Institutionen

  • Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Nephrology Unit, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
  • Pathology Unit, ASST Spedali Civili di Brescia, Brescia, Italy.

Förderung

  • Italian Ministry of Health
  • Italian Ministry of the University MUR
  • School of Medicine and Surgery
  • Department of Informatics, Systems and Communication
  • University of Milano-Bicocca

Zitieren

APA

Tedesco, M., Delbarba, E., Uzzo, M., Lugli, G., Bedognè, C., Salti, M., Ravelli, F., Damilano, C., Sestagalli, E., Arrighini, M., Fisogni, S., L'Imperio, V., Pagni, F., REASSESS Study Group, Bruchfeld, A., La Manna, G., Cozzolino, M., Sinico, R. A., Vaglio, A., …, & REASSESS Study Group (2026). Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis. Clinical Kidney Journal, 19(11). https://doi.org/10.1093/ckj/sfag350

Vancouver

Tedesco M, Delbarba E, Uzzo M, Lugli G, Bedognè C, Salti M, et al. Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis. Clinical Kidney Journal. 2026;19(11). doi:10.1093/ckj/sfag350

BibTeX
@article{Tedesco2026,
  author = {Tedesco, Martina and Delbarba, Elisa and Uzzo, Martina and Lugli, Gianmarco and Bedognè, Chiara and Salti, Marta and Ravelli, Francesco and Damilano, Corrado and Sestagalli, Eva and Arrighini, Marta and Fisogni, Simona and L'Imperio, Vincenzo and Pagni, Fabio and REASSESS Study Group, REASSESS Study Group and Bruchfeld, Annette and La Manna, Gaetano and Cozzolino, Mario and Sinico, Renato A and Vaglio, Augusto and Emmi, Giacomo and Bajema, Ingeborg and Kronbichler, Andreas and Crnogorac, Matija and McAdoo, Stephen and Little, Mark A and Jayne, David R W and Mescia, Federica and Alberici, Federico and REASSESS Study Group, REASSESS Study Group},
  title = {Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1093/ckj/sfag350}
}
Kostenlos starten →